Explore the Potential with AI-Driven Innovation
The focused library is created on demand with the latest virtual screening and parameter assessment technology, supported by the Receptor.AI drug discovery platform. This method is more effective than traditional methods and results in higher-quality compounds with better activity, selectivity, and safety.
Our selection of compounds is from a large virtual library of over 60 billion molecules. The production and distribution of these compounds are managed by our partner Reaxense.
The library features a range of promising modulators, each detailed with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Plus, each compound is presented with its ideal docking poses, affinity scores, and activity scores, ensuring a thorough insight.
We utilise our cutting-edge, exclusive workflow to develop focused libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
The method includes detailed molecular simulations of the catalytic and allosteric binding pockets, along with ensemble virtual screening that considers their conformational flexibility. In the design of modulators, structural changes induced by reaction intermediates are taken into account to enhance activity and selectivity.
Our library distinguishes itself through several key aspects:
partner
Reaxense
upacc
P61457
UPID:
PHS_HUMAN
Alternative names:
4-alpha-hydroxy-tetrahydropterin dehydratase; Dimerization cofactor of hepatocyte nuclear factor 1-alpha; Phenylalanine hydroxylase-stimulating protein; Pterin carbinolamine dehydratase
Alternative UPACC:
P61457; P70519; P80095; Q9D930
Background:
Pterin-4-alpha-carbinolamine dehydratase plays a crucial role in tetrahydrobiopterin biosynthesis, essential for neurotransmitter synthesis. It prevents the formation of 7-pterins and accelerates quinonoid-BH2 formation. Additionally, it acts as a coactivator for HNF1A and HNF1B-dependent transcription, influencing hepatocyte nuclear factor 1-alpha dimerization and transcriptional activity.
Therapeutic significance:
Linked to Hyperphenylalaninemia, BH4-deficient, D, a metabolic disorder affecting neurotransmitter synthesis, understanding Pterin-4-alpha-carbinolamine dehydratase's function could lead to novel therapeutic strategies for treating this condition.